# Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

> **NCT06256419** · NA · RECRUITING · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Susceptibility, Genetic

## Interventions

- **DRUG:** GLP-1 receptor agonist
- **DRUG:** responders group and nonresponders group

## Key facts

- **NCT ID:** NCT06256419
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06256419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06256419, "Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06256419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*